Gefitinib Tablet, Film Coated
Product Images NDC 0480-4053

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Gefitinib (NDC 0480-4053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure diagram of Gefitinib, showing its molecular framework with various rings and functional groups including oxygen, nitrogen, fluorine, and chlorine atoms, consistent with the active ingredient Gefitinib.*

FDA Label Image

New (Image 2)

Label for Gefitinib Tablets 250 mg by Teva Pharmaceuticals, Inc. The label indicates the product contains 30 film-coated oral tablets. It includes storage instructions, usage notes, and safety warnings such as keeping out of reach of children and the presence of a child-resistant closure. The NDC is 0480-4053-56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.